Pricing Log in Create free account

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) vs Niki BioSolutions, Inc. (NIKI)

CollPlant Biotechnologies Ltd. Sponsored ADR and Niki BioSolutions, Inc. are both Biotechnology companies. CollPlant Biotechnologies Ltd. Sponsored ADR and Niki BioSolutions, Inc. are of similar size ($7.0M and $6.9M). Niki BioSolutions, Inc. grew revenue faster over the last twelve months: 42.6% against −86.8%. Niki BioSolutions, Inc. has the higher net margin (−921.7% vs −3,934.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Niki BioSolutions, Inc. leads on 12 and CollPlant Biotechnologies Ltd. Sponsored ADR on 3.

Valuation

Metric CLGN NIKI Biotechnology median
P/E n/m n/m 8.50
P/S 16.34 n/m 9.71
P/B 1.76 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 24.21 1.25 9.21
Earnings yield (263.11%) (330.05%) (33.15%)
Free cash flow yield (216.45%) 0.00% (25.50%)

Profitability

Metric CLGN NIKI Biotechnology median
Gross margin (321.70%) (87.96%) 65.16%
Operating margin (3,900.94%) 0.00% 0.00%
Net margin (3,934.91%) (921.74%) 0.00%
Free cash flow margin (3,522.64%) 0.00% 0.00%
Return on equity (161.98%) 0.00% (56.36%)
Return on assets (101.59%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLGN NIKI Biotechnology median
Revenue growth (TTM) (86.76%) 42.64% 6.02%
EPS growth (last fiscal year) 35.17% 75.64% 30.26%
Revenue growth, 5-year CAGR (17.32%) 2.38% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLGN NIKI Biotechnology median
Debt to equity 0.00 0.25 0.00
Current ratio 1.57 0.78 4.72
Net debt to EBITDA 0.56 0.02 0.96

Dividend

Metric CLGN NIKI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CLGN NIKI Biotechnology median
Market cap 6.96m 6.92m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack